Published in Am J Physiol Gastrointest Liver Physiol on January 29, 2009
The coagulation system contributes to alphaVbeta6 integrin expression and liver fibrosis induced by cholestasis. Am J Pathol (2010) 1.21
Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice. Am J Pathol (2009) 1.06
Fibrinogen deficiency increases liver injury and early growth response-1 (Egr-1) expression in a model of chronic xenobiotic-induced cholestasis. Am J Pathol (2011) 0.95
Protective and damaging effects of platelets in acute cholestatic liver injury revealed by depletion and inhibition strategies. Toxicol Sci (2010) 0.94
Hepatocyte tissue factor activates the coagulation cascade in mice. Blood (2013) 0.90
Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury. Am J Pathol (2012) 0.89
Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury. Toxicol Sci (2010) 0.87
Protective effects of Moutan Cortex Radicis against acute hepatotoxicity. Afr J Tradit Complement Altern Med (2011) 0.83
Tissue factor contributes to neutrophil CD11b expression in alpha-naphthylisothiocyanate-treated mice. Toxicol Appl Pharmacol (2010) 0.83
Early growth response factor-1 limits biliary fibrosis in a model of xenobiotic-induced cholestasis in mice. Toxicol Sci (2011) 0.81
Role of hemostatic factors in hepatic injury and disease: animal models de-liver. J Thromb Haemost (2016) 0.80
Fibri(nogen) drives repair after acetaminophen-induced liver injury via leukocyte αMβ2 integrin-dependent upregulation of MMP12. J Hepatol (2016) 0.77
Coagulation in liver toxicity and disease: role of hepatocyte tissue factor. Thromb Res (2014) 0.77
Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis. J Biochem Mol Toxicol (2016) 0.77
Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injury. J Hepatol (2015) 0.77
Role of Fibrin(ogen) in Progression of Liver Disease: Guilt by Association? Semin Thromb Hemost (2016) 0.76
Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach. Arch Toxicol (2016) 0.75
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol (1989) 5.41
Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci (2005) 3.12
Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest (2004) 2.57
Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest (2008) 2.39
How the protease thrombin talks to cells. Proc Natl Acad Sci U S A (1999) 2.21
Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med (2005) 2.19
Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest (1998) 2.19
A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest (1998) 2.08
Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood (1997) 1.94
PARticipation in inflammation. J Clin Invest (2003) 1.70
Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. J Clin Invest (1998) 1.55
Tissue-specific hemostasis in mice. Arterioscler Thromb Vasc Biol (2005) 1.53
Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol (1993) 1.45
Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest (2000) 1.44
Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. Am J Physiol Gastrointest Liver Physiol (2001) 1.36
Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. Hepatology (2005) 1.34
Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors. J Hepatol (2002) 1.28
Mitochondrially-mediated toxicity of bile acids. Toxicology (2004) 1.26
Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther (1991) 1.24
Experimental cholangitis due to alpha-naphthyl-isothiocyanate (ANIT). Am J Pathol (1962) 1.24
Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Hepatology (2007) 1.23
Role of MRP2 and GSH in intrahepatic cycling of toxins. Toxicology (2001) 1.22
Intrahepatic cholestasis induced by drugs and chemicals. Pharmacol Rev (1976) 1.21
Fibrin(ogen)-alpha M beta 2 interactions regulate leukocyte function and innate immunity in vivo. Exp Biol Med (Maywood) (2004) 1.20
A monoclonal antibody that inhibits mouse tissue factor function. J Thromb Haemost (2005) 1.19
Tissue factor expression during human and mouse development. Am J Pathol (1996) 1.19
New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17
Bile secretory function of intrahepatic biliary epithelium in the rat. Am J Physiol (1989) 1.15
Cholestasis: human disease and experimental animal models. Ann Hepatol (2004) 1.12
Fibrinogen promotes neutrophil activation and delays apoptosis. J Immunol (2001) 1.11
An antibody to neutrophils attenuates alpha-naphthylisothiocyanate-induced liver injury. J Pharmacol Exp Ther (1991) 1.09
Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue. Histochemistry (1994) 1.09
Coagulation-mediated hypoxia and neutrophil-dependent hepatic injury in rats given lipopolysaccharide and ranitidine. J Pharmacol Exp Ther (2005) 1.06
Cholangiocyte injury and ductopenic syndromes. Semin Liver Dis (2007) 1.05
Acute hepatotoxicity: a predictive model based on focused illumina microarrays. Toxicol Sci (2007) 1.04
ANIT toxicity toward mouse hepatocytes in vivo is mediated primarily by neutrophils via CD18. Am J Physiol Gastrointest Liver Physiol (2006) 1.03
Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity. Am J Physiol Lung Cell Mol Physiol (2008) 1.00
Biliary epithelial cell proliferation following alpha-naphthylisothiocyanate (ANIT) treatment: relationship to bile duct obstruction. Fundam Appl Toxicol (1995) 1.00
The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat. J Pharmacol Exp Ther (1996) 0.99
Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III. Gut (1988) 0.97
Tissue factor-dependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation. Liver Transpl (2007) 0.96
The nature of alpha-naphthylisothiocyanate-induced cholestasis. Toxicol Appl Pharmacol (1965) 0.96
Novel therapeutic targets at the platelet vascular interface. Arterioscler Thromb Vasc Biol (2008) 0.96
Experimental intrahepatic obstructive jaundice following ingestion of alphanaphthyl-iso-thiocyanate. Bull Res Counc Isr Sect E Exp Med (1959) 0.95
Thrombin and protease-activated receptor-1 agonists promote lipopolysaccharide-induced hepatocellular injury in perfused livers. J Pharmacol Exp Ther (2003) 0.93
Bile duct epithelial cells exposed to alpha-naphthylisothiocyanate produce a factor that causes neutrophil-dependent hepatocellular injury in vitro. Toxicol Sci (1999) 0.93
Neutrophil- and glutathione-mediated hepatotoxicity of alpha-naphthylisothiocyanate. Drug Metab Rev (1997) 0.88
Anticoagulation and inhibition of nitric oxide synthase influence hepatic hypoxia after monocrotaline exposure. Toxicology (2006) 0.88
Platelets and alpha-naphthylisothiocyanate-induced liver injury. Toxicol Appl Pharmacol (1994) 0.88
Involvement of glutathione in 1-naphthylisothiocyanate (ANIT) metabolism and toxicity to isolated hepatocytes. Biochem Pharmacol (1991) 0.86
Characterization of apical and basolateral plasma membrane domains derived from cultured rat cholangiocytes. Anal Biochem (1997) 0.85
Blood coagulation equilibrium in rat liver microcirculation as evaluated by endothelial cell thrombomodulin and macrophage tissue factor. Thromb Res (1995) 0.85
Discordant expression of tissue factor and its activity in polarized epithelial cells. Asymmetry in anionic phospholipid availability as a possible explanation. Blood (1999) 0.85
Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis. Toxicol Sci (2004) 0.84
The effect of tissue factor pathway inhibitor on hepatic ischemic reperfusion injury of the rat. Transplantation (1999) 0.83
Anticoagulants prevent monocrotaline-induced hepatic parenchymal cell injury but not endothelial cell injury in the rat. Toxicol Appl Pharmacol (2002) 0.82
The activation of factor X by hepatocyte plasma membranes. Cell Mol Biol (1989) 0.81
Effect of antisense oligonucleotides for tissue factor on hepatic ischemia-reperfusion injury in the rat. Transplant Proc (2001) 0.79
HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell (2003) 9.12
The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem (2002) 4.28
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med (2012) 3.63
Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. J Exp Med (2007) 3.35
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood (2004) 3.31
Summary recommendations for standardization and reporting of metabolic analyses. Nat Biotechnol (2005) 2.90
Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood (2004) 2.41
Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest (2008) 2.39
Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med (2006) 2.39
TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol (2007) 2.32
Microparticles in hemostasis and thrombosis. Circ Res (2011) 2.26
Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood (2003) 2.20
Local protease signaling contributes to neural tube closure in the mouse embryo. Dev Cell (2010) 2.19
Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood (2004) 2.16
Hematopoietic and nonhematopoietic cell tissue factor activates the coagulation cascade in endotoxemic mice. Blood (2010) 2.10
The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med (2003) 1.98
Protease-activated receptor-1 contributes to cardiac remodeling and hypertrophy. Circulation (2007) 1.97
Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. EMBO J (2004) 1.94
Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol (2010) 1.91
Role of tissue factor in cancer. J Clin Oncol (2009) 1.91
Regulation of tissue factor--mediated initiation of the coagulation cascade by cell surface grp78. Arterioscler Thromb Vasc Biol (2005) 1.82
Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J Biol Chem (2002) 1.76
Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J Immunol (2008) 1.74
PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice. Arterioscler Thromb Vasc Biol (2004) 1.65
BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR. Mol Cancer Ther (2009) 1.62
Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway. Circ Res (2003) 1.59
Factor Xa binding to annexin 2 mediates signal transduction via protease-activated receptor 1. Circ Res (2008) 1.55
Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Blood (2014) 1.53
Reduced liver fibrosis in hypoxia-inducible factor-1alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol (2009) 1.52
Early growth response factor-1 is critical for cholestatic liver injury. Toxicol Sci (2006) 1.51
Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin. J Clin Invest (2012) 1.51
Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis. J Am Coll Cardiol (2013) 1.50
Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood (2007) 1.49
Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes. J Pharmacol Exp Ther (2011) 1.49
PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI. Blood (2012) 1.48
Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner. Blood (2011) 1.48
Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol (2012) 1.46
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res (2009) 1.43
Pre-existing chiasma syndromes do not entirely remit following transsphenoidal surgery for pituitary adenomas. Acta Neurochir (Wien) (2010) 1.39
Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. J Immunol (2005) 1.36
Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation. Blood (2012) 1.34
Effect of bile duct ligation on bile acid composition in mouse serum and liver. Liver Int (2011) 1.34
Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury. Blood (2008) 1.32
Role of tissue factor in haemostasis, thrombosis, angiogenesis and inflammation: lessons from low tissue factor mice. Thromb Haemost (2004) 1.28
Tissue factor: a mediator of inflammatory cell recruitment, tissue injury, and thrombus formation in experimental colitis. J Exp Med (2007) 1.27
A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice. Blood (2004) 1.26
Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest (2013) 1.24
Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin. J Biol Chem (2005) 1.24
Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J Clin Invest (2008) 1.23
Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Hepatology (2007) 1.23
Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. Cancer Res (2009) 1.22
Tissue factor in hemostasis and thrombosis. Semin Thromb Hemost (2006) 1.21
Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood (2012) 1.20
Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Res (2008) 1.19
Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood (2013) 1.19
Factor XIII activity mediates red blood cell retention in venous thrombi. J Clin Invest (2014) 1.18
Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury. Blood (2006) 1.18
Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin Thromb Hemost (2010) 1.17
Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res (2006) 1.16
COX-2 suppresses tissue factor expression via endocannabinoid-directed PPARdelta activation. J Exp Med (2007) 1.16
Tissue factor and thrombosis: The clot starts here. Thromb Haemost (2010) 1.16
Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B. J Mol Biol (2005) 1.14
Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression. J Biol Chem (2008) 1.14
Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res (2006) 1.13
Upregulation of early growth response factor-1 by bile acids requires mitogen-activated protein kinase signaling. Toxicol Appl Pharmacol (2009) 1.13
Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis. Crit Care Med (2004) 1.12
Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. J Biol Chem (2002) 1.11
Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model. Blood (2003) 1.11
PAR-1 contributes to the innate immune response during viral infection. J Clin Invest (2013) 1.09
Cellular sources of tissue factor in endotoxemia and sepsis. Thromb Res (2010) 1.09
Role of tissue factor in venous thrombosis. Annu Rev Physiol (2011) 1.09
Hepatocyte growth factor activator inhibitor-1 (HAI-1) is essential for the integrity of basement membranes in the developing placental labyrinth. Dev Biol (2006) 1.09
Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway. J Biol Chem (2008) 1.08
Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler Thromb Vasc Biol (2008) 1.08
Insulin activation of the phosphatidylinositol 3-kinase/protein kinase B (Akt) pathway reduces lipopolysaccharide-induced inflammation in mice. J Pharmacol Exp Ther (2008) 1.07
Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice. Am J Pathol (2009) 1.06
Negative regulation of p53 functions by Daxx and the involvement of MDM2. J Biol Chem (2004) 1.06
Structural insight into distinct mechanisms of protease inhibition by antibodies. Proc Natl Acad Sci U S A (2007) 1.05
Tissue Factor and Atherothrombosis. J Atheroscler Thromb (2015) 1.05
Comparative metabonomics of differential hydrazine toxicity in the rat and mouse. Toxicol Appl Pharmacol (2005) 1.05
Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy. Cancer Res (2011) 1.04
Recognition and functional activation of the human IgA receptor (FcalphaRI) by C-reactive protein. Proc Natl Acad Sci U S A (2011) 1.04
Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study. Thromb Haemost (2012) 1.04
Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay. Thromb Res (2009) 1.04
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res (2008) 1.04
Pro-urokinase-type plasminogen activator is a substrate for hepsin. J Biol Chem (2006) 1.03
Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system. Pediatr Nephrol (2008) 1.03
TLR4/CD14-mediated PI3K activation is an essential component of interferon-dependent VSV resistance in macrophages. Mol Immunol (2008) 1.02
Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies. Blood (2009) 1.01
Bacterial- and viral-induced inflammation increases sensitivity to acetaminophen hepatotoxicity. J Toxicol Environ Health A (2010) 1.01
Inhibiting alternative pathway complement activation by targeting the factor D exosite. J Biol Chem (2012) 1.01
Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol (2010) 1.00
The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet. Dig Dis Sci (2008) 0.99
Furin-cleaved proprotein convertase subtilisin/kexin type 9 (PCSK9) is active and modulates low density lipoprotein receptor and serum cholesterol levels. J Biol Chem (2012) 0.99